1mg, best e pharmacy in India

STRANTAS 250MG PREFILLED SYRINGE

generic_icon
MRP: Rs. 20000 for 1 packet(s) (5 ML prefilled syringe each)
1
Unfortunately, we don't have any more items in stock
Report Error

Composition for STRANTAS

Fulvestrant(250mg)

food interaction for STRANTAS

alcohol interaction for STRANTAS

pregnancy interaction for STRANTAS

lactation interaction for STRANTAS

food
alcohol
pregnancy
lactation
It can be taken with or without food, but it is better to take Strantas 250mg prefilled syringe at a fixed time.
Interaction with alcohol is unknown. Please consult your doctor.
Strantas 250mg prefilled syringe is unsafe to use during pregnancy.
There is positive evidence of human fetal risk, but the benefits from use in pregnant women may be acceptable despite the risk, for example in life-threatening situations. Please consult your doctor.
WEIGH RISKS VS. BENEFITS
Strantas 250mg prefilled syringe is probably unsafe to use during breastfeeding. Please consult your doctor.
UNSAFE

SALT INFORMATION for STRANTAS

Fulvestrant(250mg)

Uses

Strantas 250mg prefilled syringe is used in the treatment of breast cancer.

How it works

Strantas 250mg prefilled syringe works by blocking the action of estrogen on breast cancer cells. This can slow or stop the growth of some breast cancer that need estrogen to grow.

Common side effects

Nausea, Liver enzyme increased, Abdominal pain, Bone pain, Constipation, Cough, Diarrhoea, Headache, Hot flashes, Injection site swelling, Injection site pain, Loss of appetite, Sore throat, Vomiting, Weakness

SUBSTITUTES for STRANTAS

1 Substitutes
Sorted By
RelevancePrice
  • FULVIGLEN 250MG PREFILLED SYRINGE
    (5 ML prefilled syringe in packet)
    Glenmark Pharmaceuticals Ltd
    Rs. 3942.86/ML of prefilled syringe
    generic_icon
    Rs. 19714.28
    save 1% more per ML of prefilled syringe

Expert advice for STRANTAS

  • Fulvestrant should only be taken by women who have undergone menopause and cannot become pregnant.
  • Fulvestrant should be used with caution if you have kidney/liver problems.
  • Inform your doctor if you have any bleeding disorder, decreased platelet count, or are receiving blood-thinning medication (for example, warfarin), as fulvestrant when administered in the muscles of the buttock carries a risk of bleeding.
  • There is a potential risk of thinning or weakening of the bone (osteoporosis) with fulvestrant use. If you experience any such effects, inform your doctor immediately.
  • Fulvestrant use may lead to asthenia (lack or loss of strength and energy). If you experience such symptoms, avoid driving or operating machines.

Frequently asked questions for STRANTAS

Fulvestrant

Q.Is fulvestrant an aromatase inhibitor/chemo drug/hormone?
No, fulvestrant belongs to group of medication called as estrogen receptor antagonists. It is a chemotherapeutic drug used for the treatment of breast cancer in women who have attained menopause

Q.What is fulvestrant used for?
Fulvestrant is used in the treatment of breast cancer which has spread locally or to other parts of the body, in women who have attained menopause, and have not responded well to treatment with antiestrogen medications

Q.How is fulvestrant administered?
Fulvestrant is administered by in the muscles of the buttocks, one injection on each side, once a month; this is followed by similar doses at intervals of 2 weeks

Q.Does fulvestrant cause hair loss?
Fulvestrant has not been reported to cause hair loss.

Articles


Content on this page was last updated on 24 September, 2016, by Dr. Varun Gupta (MD Pharmacology)